Skip to main content
. 2021 Nov 20;12:20406223211056722. doi: 10.1177/20406223211056722

Table 2.

Baseline characteristics of the EFFICHRONIC study population according to the number of reported chronic conditions.

No chronic disease (n = 49) 1–2 chronic diseases (n = 166) ⩾ 3 chronic diseases (n = 55) p-value
Age, mean (SD) 55.02 (14.36) 61.98 (12.90)* 65.45 (13.00)* <0.001
Age > 65y, n (%) 11 (22.9) 68 (41.0) 25 (45.5) 0.040
Female, n (%) 35 (71.4) 134 (81.2) 42 (76.4) 0.314
BMI, mean (SD) 24.11 (4.98) 25.84 (4.83) 26.60 (4.67)* 0.026
Independency in ADL, n (%) 45 (91.8) 136 (81.9) 42 (76.4) 0.108
Independency in mobility, n (%) 41 (83.7) 141 (84.9) 44 (80.0) 0.691
Independency in IADL, n (%) 38 (77.6) 127 (76.5) 32 (58.2)* 0.022
TYM, mean (SD) 45.59 (6.21) 45.69 (3.91) 45.84 (3.33) 0.957
MNA-SF, mean (SD) 11.06 (2.33) 11.37 (2.42) 10.53 (2.45) 0.081
Medications, median (IQR) 0 (0) 2 (2)* 5 (3)* <0.001
SFES, mean (SD) 8.75 (3.24) 8.18 (2.84) 8.82 (2.68) 0.243
SELFY-MPI mean (SD) 0.09 (0.11) 0.15 (0.09)* 0.28 (0.13)* <0.001

ADL, activities of daily living; BMI, body mass index; EFFICHRONIC, Enhancing health systems sustainability by providing cost-efficiency data based interventions for chronic management in stratified population based on clinical and socio-economic determinants of health; IADL, Instrumental Activities of daily Living; IQR, interquartile range; MNA-SF, Mini Nutritional Assessment Short Form; SD, standard deviation; SELFY-MPI, Self-administered Multidimensional Prognostic Index; SFES, Social-Familial Evaluation Scale; TYM, Test Your Memory.

*

<0.05 vs “no chronic disease” group after Bonferroni correction.

<0.05 vs “1–2 chronic diseases” group after Bonferroni correction.